Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ORIC Pharmaceuticals Q2 EPS $(0.45) Misses $(0.41) Estimate

Author: Benzinga Newsdesk | August 12, 2024 04:18pm
ORIC Pharmaceuticals (NASDAQ:ORIC) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.41) by 9.76 percent. This is a 10 percent increase over losses of $(0.50) per share from the same period last year.

Posted In: ORIC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist